Dimensional Fund Advisors LP Edwards Lifesciences Corp Transaction History

Dimensional Fund Advisors LP

$449 Billion
Q3 2025

A detailed history of Dimensional Fund Advisors LP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 3,683,748 shares of EW stock, worth $318 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,683,748

Previous 3,377,894 9.05%

Holding current value

$318 Million

Previous $264 Million 8.44%

% of portfolio

0.06%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$73.75 - $81.83 $22.6 Million - $25 Million	305,854 Added 9.05%	3,683,748 $286 Million
Q2 2025 Aug 12, 2025	BUY	$67.07 - $78.22 $12.1 Million - $14.2 Million	180,902 Added 5.66%	3,377,894 $264 Million
Q1 2025 May 13, 2025	BUY	$67.95 - $76.19 $13.7 Million - $15.4 Million	201,784 Added 6.74%	3,196,992 $232 Million
Q4 2024 Feb 13, 2025	BUY	$64.54 - $75.92 $42.2 Million - $49.6 Million	653,577 Added 27.91%	2,995,208 $222 Million
Q3 2024 Nov 07, 2024	BUY	$59.7 - $93.78 $56.3 Million - $88.4 Million	942,302 Added 67.34%	2,341,631 $155 Million

Q2 2024 Aug 09, 2024	BUY	$84.3 - $94.31 $18.5 Million - $20.7 Million	219,486 Added 18.6%	1,399,329 $129 Million
Q1 2024 May 10, 2024	BUY	$72.54 - $95.56 $508,287 - $669,588	7,007 Added 0.6%	1,179,843 $113 Million
Q4 2023 Feb 07, 2024	BUY	$61.71 - $77.76 $3.61 Million - $4.54 Million	58,442 Added 5.24%	1,172,836 $89.4 Million
Q3 2023 Nov 09, 2023	BUY	$69.28 - $93.38 $173,269 - $233,543	2,501 Added 0.22%	1,114,394 $77.2 Million
Q2 2023 Aug 09, 2023	BUY	$81.41 - $94.33 $925,468 - $1.07 Million	11,368 Added 1.03%	1,111,893 $105 Million
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $806,760 - $918,116	10,864 Added 1.0%	1,100,525 $91 Million
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $1.01 Million - $1.29 Million	-14,775 Reduced 1.34%	1,089,661 $81.3 Million
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $11,531 - $15,020	140 Added 0.01%	1,104,436 $91.3 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $618,388 - $917,002	-7,149 Reduced 0.64%	1,104,296 $105 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $1.35 Million - $1.7 Million	-13,243 Reduced 1.18%	1,111,445 $131 Million
Q4 2021 Feb 09, 2022	SELL	$106.37 - $130.68 $2.46 Million - $3.02 Million	-23,142 Reduced 2.02%	1,124,688 $146 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $992,566 - $1.18 Million	9,645 Added 0.85%	1,147,830 $130 Million
Q2 2021 Aug 12, 2021	SELL	$83.84 - $104.76 $240,369 - $300,346	-2,867 Reduced 0.25%	1,138,185 $118 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $488,052 - $562,426	-6,203 Reduced 0.54%	1,141,052 $95.4 Million
Q4 2020 Feb 25, 2021	BUY	$71.69 - $91.23 $82.2 Million - $105 Million	1,147,255 New	1,147,255 $105 Million

Others Institutions Holding EW

# of Institutions

1,459

Shares Held

468M

Call Options Held

3.49M

Put Options Held

4.09M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Edwards Lifesciences Corp Transaction History